Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A04624 | 33559089 | Dig Dis Sci | Performance of Serum-Based Scores for Identification of Mild Hepatic Steatosis in HBV Mono-infected and HBV-HIV Co-infected Adults. | 2021 | Details |
| A04627 | 33558081 | Mol Genet Metab | US-FLI score - Is it possible to predict the steatosis grade with an ultrasonographic score? | 2021 | Details |
| A04637 | 33555168 | Clin Transl Gastroenterol | Clinical and Genetic Risk Factors of Recurrent Nonalcoholic Fatty Liver Disease After Liver Transplantation. | 2021 | Details |
| A04644 | 33553966 | Hepatol Commun | Nonalcoholic Fatty Liver Disease Screening in Type 2 Diabetes Mellitus Patients in the Primary Care Setting. | 2020 | Details |
| A04657 | 33549735 | Ann Hepatol | Hepatic steatosis and respiratory diseases: a new panorama. | 2021 | Details |
| A04668 | 33546191 | Biomedicines | Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and Diagnosis. | 2021 | Details |
| A04675 | 33545391 | Mol Metab | Therapeutic potential of mitochondrial uncouplers for the treatment of metabolic associated fatty liver disease and NASH. | 2021 | Details |
| A04684 | 33542919 | Biomed Res Int | Protective Effects of Iridoid Glycoside from Corni Fructus on Type 2 Diabetes with Nonalcoholic Fatty Liver in Mice. | 2021 | Details |
| A04690 | 33541129 | Exp Biol Med (Maywood) | Effect of vitamin D3 supplementation on hepatic lipid dysregulation associated with autophagy regulatory AMPK/Akt-mTOR signaling in type 2 diabetic mice. | 2021 | Details |
| A04693 | 33538526 | Gastroenterol Nurs | Gut Microbiome and Nonalcoholic Fatty Liver Disease (NAFLD): Implications for Nursing Care of Individuals Living With Chronic Metabolic Diseases. | 2021 | Details |
| A04694 | 33537464 | Biochem Biophys Rep | A high methionine and low folate diet alters glucose homeostasis and gut microbiome. | 2021 | Details |
| A04709 | 33532874 | Eur J Nutr | The effects of Chlorella supplementation on glycemic control, lipid profile and anthropometric measures on patients with type 2 diabetes mellitus. | 2021 | Details |
| A04711 | 33532498 | Biomed Res Int | Free Triiodothyronine Is Independently Associated with Nonalcoholic Fatty Liver Disease in Hospitalized Type 2 Diabetes Mellitus Patients. | 2021 | Details |
| A04723 | 33528280 | Scand J Clin Lab Invest | Chronic inflammation involves CCL11 and IL-13 to facilitate the development of liver cirrhosis and fibrosis in chronic hepatitis B virus infection. | 2021 | Details |
| A04726 | 33526312 | Clin Ther | Nonalcoholic Fatty Liver Disease: A Global Perspective. | 2021 | Details |
| A04738 | 33520463 | PeerJ | The association between serum uric acid and diabetic complications in patients with type 2 diabetes mellitus by gender: a cross-sectional study. | 2021 | Details |
| A04742 | 33517613 | Diabetes Metab J | Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A04758 | 33513761 | Metabolites | Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials. | 2021 | Details |
| A04768 | 33511287 | Clin Exp Hepatol | Comparison of knowledge and awareness between consultant physicians and resident doctors about non-alcoholic fatty liver disease. | 2020 | Details |
| A04769 | 33511282 | Clin Exp Hepatol | SGLT2 inhibitors for improving hepatic fibrosis and steatosis in non-alcoholic fatty liver disease complicated with type 2 diabetes mellitus: a systematic review. | 2020 | Details |
| A04773 | 33511092 | Front Pediatr | Childhood and Adolescent Obesity: A Review. | 2021 | Details |
| A04775 | 33510844 | Oxid Med Cell Longev | Phloroglucinol Strengthens the Antioxidant Barrier and Reduces Oxidative/Nitrosative Stress in Nonalcoholic Fatty Liver Disease (NAFLD). | 2021 | Details |
| A04776 | 33510172 | Nat Commun | CD4 derived double negative T cells prevent the development and progression of nonalcoholic steatohepatitis. | 2021 | Details |
| A04781 | 33506689 | J Am Heart Assoc | Liver Fibrosis Scoring Systems as Novel Tools for Predicting Cardiovascular Outcomes in Patients Following Elective Percutaneous Coronary Intervention. | 2021 | Details |
| A04784 | 33505944 | Can J Gastroenterol Hepatol | Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases: The Heart of the Matter. | 2021 | Details |
| A04797 | 33503878 | Nutrients | Incretin Hormones in Obesity and Related Cardiometabolic Disorders: The Clinical Perspective. | 2021 | Details |
| A04802 | 33501527 | J Gen Intern Med | Predicting Non-Alcoholic Fatty Liver Disease for Adults Using Practical Clinical Measures: Evidence from the Multi-ethnic Study of Atherosclerosis. | 2021 | Details |
| A04805 | 33499062 | Biomolecules | The Mitochondrial Citrate Carrier SLC25A1/CIC and the Fundamental Role of Citrate in Cancer, Inflammation and Beyond. | 2021 | Details |
| A04814 | 33497019 | Liver Int | Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis. | 2021 | Details |
| A04816 | 33496855 | Acta Diabetol | Lack of awareness of liver organ damage in patients with type 2 diabetes. | 2021 | Details |
| A04835 | 33490615 | JGH Open | Seroprevalence of Helicobacter pylori and its association with metabolic syndrome in a rural community of Bangladesh. | 2020 | Details |
| A04836 | 33490240 | Biomed Res Int | Association between Triglyceride-Glucose Index and Type 2 Diabetes Mellitus in the Japanese Population: A Secondary Analysis of a Retrospective Cohort Study. | 2020 | Details |
| A04845 | 33486379 | Comput Biol Med | A meta-analysis of comorbidities in COVID-19: Which diseases increase the susceptibility of SARS-CoV-2 infection? | 2021 | Details |
| A04853 | 33482185 | Life Sci | Beinaglutide shows significantly beneficial effects in diabetes/obesity-induced nonalcoholic steatohepatitis in ob/ob mouse model. | 2021 | Details |
| A04857 | 33479589 | Diabetol Int | Improved insulin sensitivity with sodium-glucose cotransporter 2 inhibitor treatment in a patient with slowly progressive type 1 diabetes mellitus with metabolic syndrome: a case report. | 2020 | Details |
| A04859 | 33479072 | Clin Med (Lond) | Image of the month: Mauriac variant: a rare complication of poorly controlled diabetes. | 2021 | Details |
| A04863 | 33477579 | J Clin Med | Association of NAFLD and Insulin Resistance with Non Metastatic Bladder Cancer Patients: A Cross-Sectional Retrospective Study. | 2021 | Details |
| A04880 | 33469809 | Dig Dis Sci | Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, "Prediabetes," Diabetes and Atherosclerosis. | 2021 | Details |
| A04892 | 33464703 | Diabetes Obes Metab | Combined exenatide and dapagliflozin has no additive effects on reduction of hepatocellular lipids despite better glycaemic control in patients with type 2 diabetes mellitus treated with metformin: EXENDA, a 24-week, prospective, randomized, placebo-controlled pilot trial. | 2021 | Details |
| A04894 | 33464677 | Diabetes Obes Metab | Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review. | 2021 | Details |
| A04904 | 33457424 | J Diabetes Res | Effects of Sodium-Glucose Cotransporter 2 Inhibition on Glucose Metabolism, Liver Function, Ascites, and Hemodynamics in a Mouse Model of Nonalcoholic Steatohepatitis and Type 2 Diabetes. | 2020 | Details |
| A04907 | 33455863 | Trends Endocrinol Metab | Role of Macrophages in the Endocrine System. | 2021 | Details |
| A04926 | 33446705 | Sci Rep | Laparoscopic sleeve gastrectomy alters 1H-NMR-measured lipoprotein and glycoprotein profile in patients with severe obesity and nonalcoholic fatty liver disease. | 2021 | Details |
| A04932 | 33445096 | J Affect Disord | Effects of Alpha-2-HS-glycoprotein on cognitive and emotional assessment in prediabetic and diabetic subjects. | 2020 | Details |
| A04940 | 33442452 | World J Hepatol | Effects of proprotein convertase subtilisin/kexin type-9 inhibitors on fatty liver. | 2020 | Details |
| A04941 | 33442450 | World J Hepatol | Validation of genetic variants associated with metabolic dysfunction-associated fatty liver disease in an ethnic Chinese population. | 2020 | Details |
| A04950 | 33439540 | J Gastroenterol Hepatol | The impact of sodium glucose co-transporter 2 inhibitors on non-alcoholic fatty liver disease. | 2020 | Details |
| A04956 | 33437903 | Hepatol Commun | The Natural History of NAFLD, a Community-Based Study at a Large Health Care Delivery System in the United States. | 2020 | Details |
| A04961 | 33437782 | Ann Transl Med | Clinical implications of serum Mac-2-binding protein glycan isomer as a novel biomarker of advanced hepatic fibrosis in diabetes. | 2020 | Details |
| A04962 | 33437731 | Med J Islam Repub Iran | Liver fat content might be an appropriate measure for estimation of cardiovascular disease risk in non-alcoholic steatohepatitis patients. | 2020 | Details |
| A04980 | 33428035 | Dig Dis Sci | Hepamet Fibrosis Score in Nonalcoholic Fatty Liver Disease Patients in Mexico: Lower than Expected Positive Predictive Value. | 2021 | Details |
| A04985 | 33425804 | Can J Gastroenterol Hepatol | Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional Relationship. | 2020 | Details |
| A04989 | 33422644 | Mol Metab | Neonatal overfeeding during lactation rapidly and permanently misaligns the hepatic circadian rhythm and programmes adult NAFLD. | 2021 | Details |
| A04993 | 33421947 | EBioMedicine | A novel GLP-1 and FGF21 dual agonist has therapeutic potential for diabetes and non-alcoholic steatohepatitis. | 2021 | Details |
| A04997 | 33421258 | J Biochem Mol Toxicol | The protective effects of trelagliptin on high-fat diet-induced nonalcoholic fatty liver disease in mice. | 2021 | Details |
| A05007 | 33413363 | Cardiovasc Diabetol | Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study. | 2021 | Details |
| A05010 | 33411970 | J Diabetes Investig | Sex differences in the association between fatty liver and type 2 diabetes incidence in non-obese Japanese: A retrospective cohort study. | 2021 | Details |
| A05014 | 33409801 | Dig Dis Sci | Perception of Illness and Its Association with Treatment Willingness in Patients with Newly Diagnosed Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A05016 | 33409407 | Transl Gastroenterol Hepatol | Metabolic syndrome following liver transplantation in nonalcoholic steatohepatitis. | 2021 | Details |
| A05026 | 33406286 | Int J Clin Pract | Small intestinal bacterial overgrowth and non-alcoholic fatty liver disease diagnosed by transient elastography and liver biopsy. | 2021 | Details |
| A05040 | 33397443 | Biol Sex Differ | Gender differences in the efficacy of pioglitazone treatment in nonalcoholic fatty liver disease patients with abnormal glucose metabolism. | 2021 | Details |
| A05041 | 33397230 | Curr Pharm Des | Serum Uric Acid and Diabetes: From Pathophysiology to Cardiovascular Disease. | 2021 | Details |
| A05042 | 33396949 | Metabolites | Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials. | 2020 | Details |
| A05049 | 33394807 | Eur J Gastroenterol Hepatol | The association of impaired lung function and nonalcoholic fatty liver disease: a systematic review. | 2021 | Details |
| A05050 | 33394549 | Diabetes Obes Metab | Nonalcoholic fatty liver disease, diastolic dysfunction, and impaired myocardial glucose uptake in patients with type 2 diabetes. | 2021 | Details |
| A05052 | 33392801 | Curr Atheroscler Rep | Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα) in the Metabolic Syndrome: Is Pemafibrate Light at the End of the Tunnel? | 2021 | Details |
| A05066 | 33389416 | Dig Dis Sci | A Stepwise Algorithmic Approach and External Validation Study for Noninvasive Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A05080 | 33385317 | J Dig Dis | Efficacy and safety of drugs for nonalcoholic steatohepatitis. | 2021 | Details |
| A05083 | 33384552 | World J Gastroenterol | Prevalence and associated factors of obesity in inflammatory bowel disease: A case-control study. | 2020 | Details |
| A05095 | 33378413 | PLoS One | A CD209 ligand and a sialidase inhibitor differentially modulate adipose tissue and liver macrophage populations and steatosis in mice on the Methionine and Choline-Deficient (MCD) diet. | 2020 | Details |
| A05096 | 33378048 | Eur Rev Med Pharmacol Sci | Gut microbiota and its metabolic potential. | 2020 | Details |
| A05098 | 33377125 | Cell Rep Med | Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes. | 2020 | Details |
| A05102 | 33376110 | BMJ Open Gastroenterol | Prevalence, risk factors and metabolic profile of the non-obese and obese non-alcoholic fatty liver disease in a rural community of South Asia. | 2020 | Details |
| A05110 | 33372390 | J Diabetes Investig | Association of non-alcoholic fatty liver disease with diabetic retinopathy in type 2 diabetic patients: A meta-analysis of observational studies. | 2021 | Details |
| A05116 | 33370454 | J Gastroenterol Hepatol | Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetes. | 2021 | Details |
| A05123 | 33364879 | Sisli Etfal Hastan Tip Bul | The Relationship between Insulin Resistance and Liver Damage in non-alcoholic Fatty Liver Patients. | 2020 | Details |
| A05137 | 33359401 | Mol Metab | Insulin resistance is mechanistically linked to hepatic mitochondrial remodeling in non-alcoholic fatty liver disease. | 2020 | Details |
| A05138 | 33359400 | Mol Metab | Nuclear hormone and peptide hormone therapeutics for NAFLD and NASH. | 2020 | Details |
| A05146 | 33355256 | Diabetes Care | Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening. | 2020 | Details |
| A05156 | 33352183 | Eur J Pharmacol | The effects of glucagon-like peptide-1 receptor agonists on glycemic control and anthropometric profiles among diabetic patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials. | 2020 | Details |
| A05164 | 33348109 | Nutrition | Development and course of diabetes according to genetic factors and diabetes treatment among patients with nonalcoholic fatty liver disease. | 2020 | Details |
| A05172 | 33346905 | Protein Cell | The role of the gut microbiome and its metabolites in metabolic diseases. | 2020 | Details |
| A05175 | 33346465 | Ter Arkh | [Non-alcoholic fatty liver disease and type 2 diabetes mellitus: issues of the liver fibrosis diagnostics]. | 2020 | Details |
| A05176 | 33346459 | Ter Arkh | [Clinical features of the comorbid course of non-alcoholic fatty liver disease and gallstone disease]. | 2020 | Details |
| A05193 | 33341026 | Phytomedicine | Δ9-Tetrahydrocannabinolic Acid markedly alleviates liver fibrosis and inflammation in mice. | 2020 | Details |
| A05213 | 33336648 | Diabetes Metab Syndr | Nonalcoholic fatty liver disease should be considered for treatment allocation in standard management algorithms for type 2 diabetes. | 2020 | Details |
| A05215 | 33336025 | Open Med (Wars) | Effect of glucagon-like peptide-1 receptor agonists on adipokine level of nonalcoholic fatty liver disease in rats fed high-fat diet. | 2020 | Details |
| A05218 | 33334622 | Arch Med Res | Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05241 | 33327335 | Medicine (Baltimore) | Comparison of noninvasive scoring systems for the prediction of nonalcoholic fatty liver disease in metabolic syndrome patients. | 2020 | Details |
| A05251 | 33323806 | Chin Med J (Engl) | MAFLD vs. NAFLD: shared features and potential changes in epidemiology, pathophysiology, diagnosis, and pharmacotherapy. | 2020 | Details |
| A05261 | 33320482 | Postepy Biochem | Transcription factor ChREBP – the coordinator of carbohydrate and lipid metabolism | 2020 | Details |
| A05267 | 33319051 | JGH Open | Use of simple scoring systems for a public health approach in the management of non-alcoholic fatty liver disease patients. | 2020 | Details |
| A05274 | 33317243 | Clin Mol Hepatol | Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease. | 2020 | Details |
| A05291 | 33310947 | Wiad Lek | CORRECTION OF AUTONOMIC AND COGNITIVE DISTURBANCES IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE. | 2020 | Details |
| A05297 | 33309563 | Clin Res Hepatol Gastroenterol | Liraglutide in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials. | 2020 | Details |
| A05298 | 33309070 | Clin Investig Arterioscler | Approach to the cardiometabolic continuum. Narrative description. | 2020 | Details |
| A05307 | 33307021 | Gastroenterology | AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review. | 2020 | Details |
| A05310 | 33306598 | J Chin Med Assoc | Interleukin-2 receptor alpha as a biomarker for nonalcoholic fatty liver disease diagnosis. | 2021 | Details |
| A05320 | 33303638 | Diabetes Care | High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes. | 2020 | Details |
| A05322 | 33302841 | Curr Hypertens Rev | Nonalcoholic Fatty Liver Disease (NAFLD) for Primary Care Providers: Beyond the Liver. | 2021 | Details |